Ulcerative Colitis Stocks List

Ulcerative Colitis Stocks Recent News

Date Stock Title
Nov 1 LXRX Sector Update: Health Care Stocks Rise Late Afternoon
Nov 1 ABBV Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
Nov 1 ABBV Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1 LXRX Top Midday Decliners
Nov 1 BHC Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
Nov 1 ABBV AbbVie Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nov 1 LXRX Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Nov 1 ABBV AbbVie and EvolveImmune Therapeutics sign oncology collaboration
Nov 1 ABBV 5 Stocks That Recently Announced Dividend Hikes
Nov 1 ABBV Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
Nov 1 ABBV Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
Nov 1 GLPG Galapagos NV (GLPG) Q3 2024 Earnings Call Highlights: Strong Cash Position and R&D Progress ...
Oct 31 LXRX Lexicon Announces Outcome of FDA Advisory Committee for Zynquistaâ„¢ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
Oct 31 LXRX Lexicon's sotagliflozin fails to win support of FDA AdComm for diabetes (update)
Oct 31 GLPG Galapagos NV 2024 Q3 - Results - Earnings Call Presentation
Oct 31 GLPG Galapagos NV (GLPG) Q3 2024 Earnings Call Transcript
Oct 31 ABBV AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
Oct 31 ABBV AbbVie announces 2025 dividend increase of 5.8% to $1.64 from $1.55 per share
Oct 31 ABBV 5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
Oct 31 BHC Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
Ulcerative Colitis

Ulcerative colitis (UC) is a long-term condition that results in inflammation and ulcers of the colon and rectum. The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood. Weight loss, fever, and anemia may also occur. Often, symptoms come on slowly and can range from mild to severe. Symptoms typically occur intermittently with periods of no symptoms between flares. Complications may include megacolon, inflammation of the eye, joints, or liver, and colon cancer.The cause of UC is unknown. Theories involve immune system dysfunction, genetics, changes in the normal gut bacteria, and environmental factors. Rates tend to be higher in the developed world with some proposing this to be the result of less exposure to intestinal infections, or to a Western diet and lifestyle. The removal of the appendix at an early age may be protective. Diagnosis is typically by colonoscopy with tissue biopsies. It is a kind of inflammatory bowel disease (IBD) along with Crohn's disease and microscopic colitis.Dietary changes, such as maintaining a high-calorie diet or lactose-free diet, may improve symptoms. Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. Removal of the colon and rectum can cure the disease.Together with Crohn's disease, about 11.2 million people were affected as of 2015. Each year it newly occurs in 1 to 20 per 100,000 people, and 5 to 500 per 100,000 individuals are affected. The disease is more common in North America and Europe than other regions. Often it begins in people aged 15 to 30 years, or among those over 60. Males and females appear to be affected in equal proportions. It has also become more common since the 1950s. Together, ulcerative colitis and Crohn's disease affect about a million people in the United States. With appropriate treatment the risk of death appears the same as that of the general population. The first description of ulcerative colitis occurred around the 1850s.

Browse All Tags